Related references
Note: Only part of the references are listed.Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens
Brenda Carrillo-Conde et al.
ACTA BIOMATERIALIA (2010)
Pulmonary Targeting of Nanoparticle Drug Matrices
Preshit Dandekar et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2010)
Protein adsorption on biodegradable polyanhydride microparticles
Brenda Carrillo-Conde et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2010)
The simultaneous effect of polymer chemistry and device geometry on the in vitro activation of murine dendritic cells
Latrisha K. Petersen et al.
BIOMATERIALS (2009)
Different Pathologies but Equal Levels of Responsiveness to the Recombinant F1 and V Antigen Vaccine and Ciprofloxacin in a Murine Model of Plague Caused by Small- and Large-Particle Aerosols
Richard J. Thomas et al.
INFECTION AND IMMUNITY (2009)
Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of V antigen of Yersinia pestis by intranasal immunization in microparticles
Jayaprakash Babu Uppada et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2009)
Polymer Chemistry Influences Monocytic Uptake of Polyanhydride Nanospheres
Bret D. Ulery et al.
PHARMACEUTICAL RESEARCH (2009)
Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant
Yong Sung Park et al.
INFECTION AND IMMUNITY (2008)
Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine
Christina L. Airhart et al.
VACCINE (2008)
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Sai T. Reddy et al.
NATURE BIOTECHNOLOGY (2007)
A plant-produced plague vaccine candidate confers protection to monkeys
Vadim Mett et al.
VACCINE (2007)
Amphiphilic polyanhydrides for protein stabilization and release
Maria P. Torres et al.
BIOMATERIALS (2007)
Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen
Maria J. Chiuchiolo et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine
SJ Elvin et al.
VACCINE (2006)
Protein stability in the presence of polymer degradation products: Consequences for controlled release formulations
AS Determan et al.
BIOMATERIALS (2006)
Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis
C Cowan et al.
INFECTION AND IMMUNITY (2005)
Can successful vaccines teach us how to induce efficient protective immune responses?
PH Lambert et al.
NATURE MEDICINE (2005)
Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens
A Glynn et al.
VACCINE (2005)
Visualizing the first 50 Hr of the primary immune response to a soluble antigen
DM Catron et al.
IMMUNITY (2004)
Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response
CA Siegrist et al.
VACCINE (2004)
Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres
AS Determan et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Correlates of immunity for pneumococcal conjugate vaccines
LH Lee et al.
VACCINE (2003)
Share Paper
